Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$116K Sell
328
-464
-59% -$165K 0.08% 232
2025
Q4
$259K Buy
792
+178
+29% +$56.5K 0.14% 137
2025
Q3
$173K Buy
614
+130
+27% +$37.7K 0.1% 267
2025
Q2
$135K Buy
484
+14
+3% +$3.97K 0.08% 377
2025
Q1
$146K Buy
470
+41
+10% +$12.1K 0.1% 261
2024
Q4
$112K Sell
429
-28
-6% -$8.31K 0.07% 449
2024
Q3
$148K Sell
457
-653
-59% -$214K 0.09% 314
2024
Q2
$348K Buy
1,110
+333
+43% +$97.8K 0.23% 41
2024
Q1
$220K Sell
777
-179
-19% -$52.4K 0.14% 133
2023
Q4
$274K Sell
956
-99
-9% -$27K 0.19% 58
2023
Q3
$283K Buy
1,055
+335
+47% +$83.6K 0.21% 48
2023
Q2
$160K Buy
720
+87
+14% +$20.2K 0.12% 197
2023
Q1
$153K Sell
633
-6
-0.9% -$1.47K 0.13% 191
2022
Q4
$168K Sell
639
-3
-0.5% -$804 0.14% 171
2022
Q3
$145K Sell
642
-224
-26% -$54.3K 0.13% 175
2022
Q2
$211K Sell
866
-20
-2% -$4.9K 0.17% 106
2022
Q1
$214K Buy
886
+338
+62% +$77.7K 0.14% 134
2021
Q4
$123K Buy
+548
New +$116K 0.17% 91

Other funds holding AMGN

Covestor's AMGN Position: Q1 2026 in Review

Covestor reduced its Amgen (AMGN) stake by 59% in Q1 2026, selling an estimated $165K and leaving 328 shares worth $116K. The position accounts for 0.08% of the portfolio, ranked #232.

Covestor first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $348K in Q2 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Covestor held 328 shares of Amgen worth $116K as of Q1 2026.
  • Covestor sold 464 Amgen shares in Q1 2026, an estimated $165K.
  • Amgen made up 0.08% of Covestor's portfolio in Q1 2026, its #232 holding.
  • Covestor first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • Covestor's Amgen position peaked at $348K in Q2 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.